Wird geladen...
2015 Guidance on cancer immunotherapy development in early‐phase clinical studies
The development of cancer immunotherapies is progressing rapidly with a variety of technological approaches. They consist of “cancer vaccines”, which are based on the idea of vaccination, “effector cell therapy”, classified as passive immunotherapy, and “inhibition of immunosuppression”, which inten...
Gespeichert in:
Veröffentlicht in: | Cancer Sci |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
John Wiley and Sons Inc.
2015
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4714668/ https://ncbi.nlm.nih.gov/pubmed/26767933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12819 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|